| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KATNAL2 SPIRE2 MYO9A SPATA31A7 TOGARAM1 MAST2 SPATA31A6 SPATA31C1 PRUNE1 PTPN3 NAV3 KIF28P GNAS MYO18B CAMSAP1 WASF1 PDLIM2 MICAL1 LIMA1 SPATA31A3 ANK2 OFD1 KIF26B CCDC187 SORBS1 SPATA31A5 SETD2 SPATA31A1 XIRP2 MICAL2 WASF2 FHOD1 SIPA1L1 MARK4 ENAH CDK5RAP2 FHDC1 TRAPPC14 | 7.44e-12 | 1099 | 195 | 38 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | SPIRE2 MYO9A SPATA31A7 SPATA31A6 SPATA31C1 MYO18B WASF1 PDLIM2 MICAL1 LIMA1 SPATA31A3 SORBS1 SPATA31A5 SPATA31A1 XIRP2 MICAL2 WASF2 FHOD1 SIPA1L1 ENAH FHDC1 | 1.03e-08 | 479 | 195 | 21 | GO:0003779 |
| GeneOntologyMolecularFunction | tubulin binding | KATNAL2 SPIRE2 TOGARAM1 MAST2 PRUNE1 NAV3 KIF28P GNAS CAMSAP1 OFD1 KIF26B CCDC187 SETD2 MARK4 CDK5RAP2 FHDC1 TRAPPC14 | 1.11e-06 | 428 | 195 | 17 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | KATNAL2 SPIRE2 TOGARAM1 MAST2 NAV3 KIF28P CAMSAP1 KIF26B CCDC187 MARK4 CDK5RAP2 FHDC1 | 5.31e-05 | 308 | 195 | 12 | GO:0008017 |
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK4 ACAP1 TBC1D9B MYO9A ARHGAP26 SIPA1L3 ARHGEF11 RASAL2 ARHGEF1 SIPA1L1 ARHGAP28 | 9.81e-05 | 279 | 195 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK4 ACAP1 TBC1D9B MYO9A ARHGAP26 SIPA1L3 ARHGEF11 DENND2B HPS4 RASAL2 PLEKHG7 ARHGEF1 SIPA1L1 ARHGAP28 PLCE1 | 1.44e-04 | 507 | 195 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK4 ACAP1 TBC1D9B MYO9A ARHGAP26 SIPA1L3 ARHGEF11 DENND2B HPS4 RASAL2 PLEKHG7 ARHGEF1 SIPA1L1 ARHGAP28 PLCE1 | 1.44e-04 | 507 | 195 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor 1 binding | 5.62e-04 | 4 | 195 | 2 | GO:0051430 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 7.38e-04 | 42 | 195 | 4 | GO:0098918 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SPIRE2 ARHGAP26 TSC1 ARHGEF11 ZEB2 GRID2IP FGR MYO18B WASF1 PDLIM2 SHANK1 MICAL1 LIMA1 PCLO SORBS1 XIRP2 MICAL2 WASF2 FHOD1 SIPA1L1 ENAH ARHGAP28 FHDC1 | 1.76e-06 | 803 | 192 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | SPIRE2 TSC1 ZEB2 SHANK1 MICAL1 LIMA1 SORBS1 WASF2 FHOD1 ARHGAP28 FHDC1 | 1.84e-06 | 191 | 192 | 11 | GO:0051017 |
| GeneOntologyBiologicalProcess | actin filament bundle organization | SPIRE2 TSC1 ZEB2 SHANK1 MICAL1 LIMA1 SORBS1 WASF2 FHOD1 ARHGAP28 FHDC1 | 2.25e-06 | 195 | 192 | 11 | GO:0061572 |
| GeneOntologyBiologicalProcess | actin filament-based process | SPIRE2 ARHGAP26 TSC1 ARHGEF11 ZEB2 GRID2IP FGR MYO18B WASF1 PDLIM2 SHANK1 MICAL1 LIMA1 ANK2 PCLO SORBS1 XIRP2 MICAL2 WASF2 FHOD1 SIPA1L1 ENAH ARHGAP28 FHDC1 | 4.46e-06 | 912 | 192 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KATNAL2 SPIRE2 TOGARAM1 TSC1 ZEB2 PRUNE1 NAV3 CAMSAP1 WASF1 SHANK1 MICAL1 LIMA1 SORBS1 XIRP2 MICAL2 ARHGEF1 WASF2 FHOD1 ENAH CDK5RAP2 ARHGAP28 FHDC1 PCM1 | 3.03e-05 | 957 | 192 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | sulfur oxidation | 8.62e-05 | 2 | 192 | 2 | GO:0019417 | |
| GeneOntologyBiologicalProcess | actin filament organization | SPIRE2 TSC1 ZEB2 WASF1 SHANK1 MICAL1 LIMA1 SORBS1 XIRP2 MICAL2 WASF2 FHOD1 ENAH ARHGAP28 FHDC1 | 8.87e-05 | 509 | 192 | 15 | GO:0007015 |
| GeneOntologyBiologicalProcess | organelle localization | SPHK2 SPIRE2 RBM10 TSC1 KCNB1 SEC16A KIF28P RIPOR1 FGR BSN WASF1 TCF7L2 PPFIA2 PCLO NUP88 FHOD1 CDK5RAP2 PCM1 | 1.06e-04 | 703 | 192 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | NES TOGARAM1 TSC1 PRUNE1 NAV3 FGR CAMSAP1 WASF1 SHANK1 LIMA1 XIRP2 WASF2 FHOD1 CDK5RAP2 ARHGAP28 AGRN | 1.09e-04 | 579 | 192 | 16 | GO:0051493 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK4 MYO9A ARHGAP26 SIPA1L3 ARHGEF11 PRAG1 RIPOR1 WASF1 PLEKHG7 ARHGEF1 WASF2 SIPA1L1 ARHGAP28 AGRN PLCE1 | 1.63e-04 | 538 | 192 | 15 | GO:0007264 |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 1.89e-04 | 127 | 192 | 7 | GO:0030038 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 1.89e-04 | 127 | 192 | 7 | GO:0043149 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | SPHK2 SPIRE2 RBM10 TSC1 SEC16A KIF28P RIPOR1 FGR WASF1 PPFIA2 PCLO NUP88 FHOD1 CDK5RAP2 PCM1 | 1.91e-04 | 546 | 192 | 15 | GO:0051656 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO9A SIPA1L3 TSC1 FGR MYO18B WASF1 PDLIM2 WHRN MICAL1 LIMA1 SORBS1 XIRP2 MICAL2 WASF2 FHOD1 SIPA1L1 ENAH RAI14 FHDC1 | 1.76e-06 | 576 | 193 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 6.82e-06 | 107 | 193 | 8 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 6.82e-06 | 107 | 193 | 8 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 1.32e-05 | 117 | 193 | 8 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.40e-05 | 118 | 193 | 8 | GO:0032432 | |
| GeneOntologyCellularComponent | actin filament | 6.49e-05 | 146 | 193 | 8 | GO:0005884 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 2.07e-04 | 13 | 193 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | USH2 complex | 5.03e-04 | 4 | 193 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | anchoring junction | DCAF6 IL16 ARHGAP26 SIPA1L3 MAST2 PRAG1 PRUNE1 WASF1 PDLIM2 LIMA1 ANK2 FBF1 SORBS1 AKAP12 XIRP2 WASF2 FHOD1 ENAH RAI14 TJP3 | 7.28e-04 | 976 | 193 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | cone cell pedicle | 8.33e-04 | 5 | 193 | 2 | GO:0044316 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.24e-03 | 6 | 193 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.24e-03 | 6 | 193 | 2 | GO:0002142 | |
| Domain | PDZ | IL16 SIPA1L3 PDZD7 ARHGEF11 MAST2 PTPN3 GRID2IP MAST4 PDLIM2 SHANK1 WHRN PCLO SIPA1L1 TJP3 | 4.60e-10 | 151 | 190 | 14 | PS50106 |
| Domain | PDZ | IL16 SIPA1L3 PDZD7 ARHGEF11 MAST2 PTPN3 GRID2IP MAST4 PDLIM2 SHANK1 WHRN PCLO SIPA1L1 TJP3 | 5.02e-10 | 152 | 190 | 14 | IPR001478 |
| Domain | PDZ | IL16 SIPA1L3 PDZD7 ARHGEF11 MAST2 PTPN3 GRID2IP MAST4 PDLIM2 SHANK1 WHRN SIPA1L1 TJP3 | 2.10e-09 | 141 | 190 | 13 | PF00595 |
| Domain | PDZ | IL16 SIPA1L3 PDZD7 ARHGEF11 MAST2 PTPN3 GRID2IP MAST4 PDLIM2 SHANK1 WHRN SIPA1L1 TJP3 | 3.81e-09 | 148 | 190 | 13 | SM00228 |
| Domain | - | IL16 SIPA1L3 PDZD7 ARHGEF11 MAST2 PTPN3 GRID2IP MAST4 PDLIM2 SHANK1 WHRN SIPA1L1 TJP3 | 4.49e-09 | 150 | 190 | 13 | 2.30.42.10 |
| Domain | DUF4599 | 7.73e-08 | 12 | 190 | 5 | PF15371 | |
| Domain | DUF4599 | 7.73e-08 | 12 | 190 | 5 | IPR027970 | |
| Domain | Znf_piccolo | 1.03e-04 | 2 | 190 | 2 | IPR008899 | |
| Domain | zf-piccolo | 1.03e-04 | 2 | 190 | 2 | PF05715 | |
| Domain | UBA | 2.31e-04 | 30 | 190 | 4 | SM00165 | |
| Domain | SCAR/WAVE_fam | 3.07e-04 | 3 | 190 | 2 | IPR028288 | |
| Domain | RGS-like_dom | 3.07e-04 | 3 | 190 | 2 | IPR015212 | |
| Domain | SPAR_C | 3.07e-04 | 3 | 190 | 2 | PF11881 | |
| Domain | RGS-like | 3.07e-04 | 3 | 190 | 2 | PF09128 | |
| Domain | SIPA1L_C | 3.07e-04 | 3 | 190 | 2 | IPR021818 | |
| Domain | cNMP | 3.79e-04 | 34 | 190 | 4 | SM00100 | |
| Domain | cNMP-bd_dom | 4.25e-04 | 35 | 190 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 4.25e-04 | 35 | 190 | 4 | PS50042 | |
| Domain | FH2 | 4.31e-04 | 15 | 190 | 3 | PS51444 | |
| Domain | FH2_Formin | 4.31e-04 | 15 | 190 | 3 | IPR015425 | |
| Domain | FH2 | 4.31e-04 | 15 | 190 | 3 | PF02181 | |
| Domain | FH2 | 4.31e-04 | 15 | 190 | 3 | SM00498 | |
| Domain | UBA | 4.74e-04 | 36 | 190 | 4 | PF00627 | |
| Domain | cNMP-bd-like | 5.84e-04 | 38 | 190 | 4 | IPR018490 | |
| Domain | CTNNB1_binding | 6.09e-04 | 4 | 190 | 2 | PF08347 | |
| Domain | TCF/LEF | 6.09e-04 | 4 | 190 | 2 | IPR024940 | |
| Domain | DUF1908 | 6.09e-04 | 4 | 190 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 6.09e-04 | 4 | 190 | 2 | IPR015022 | |
| Domain | CTNNB1-bd_N | 6.09e-04 | 4 | 190 | 2 | IPR013558 | |
| Domain | MAST_pre-PK_dom | 6.09e-04 | 4 | 190 | 2 | IPR023142 | |
| Domain | - | 6.09e-04 | 4 | 190 | 2 | 1.20.1480.20 | |
| Domain | LIM | 6.86e-04 | 69 | 190 | 5 | PF00412 | |
| Domain | - | 7.32e-04 | 70 | 190 | 5 | 2.10.110.10 | |
| Domain | LIM | 7.82e-04 | 71 | 190 | 5 | SM00132 | |
| Domain | Znf_LIM | 7.82e-04 | 71 | 190 | 5 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 7.82e-04 | 71 | 190 | 5 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 7.82e-04 | 71 | 190 | 5 | PS50023 | |
| Domain | CH | 8.87e-04 | 73 | 190 | 5 | PS50021 | |
| Domain | CH-domain | 1.00e-03 | 75 | 190 | 5 | IPR001715 | |
| Domain | NUT | 1.01e-03 | 5 | 190 | 2 | IPR024310 | |
| Domain | NUT_N | 1.01e-03 | 5 | 190 | 2 | IPR024309 | |
| Domain | NUT | 1.01e-03 | 5 | 190 | 2 | PF12881 | |
| Domain | UBA | 1.02e-03 | 44 | 190 | 4 | IPR015940 | |
| Domain | WH2_dom | 1.20e-03 | 21 | 190 | 3 | IPR003124 | |
| Domain | UBA | 1.32e-03 | 47 | 190 | 4 | PS50030 | |
| Domain | - | 1.42e-03 | 48 | 190 | 4 | 2.60.120.10 | |
| Domain | FAD-bd | 1.50e-03 | 6 | 190 | 2 | IPR002938 | |
| Domain | FAD_binding_3 | 1.50e-03 | 6 | 190 | 2 | PF01494 | |
| Domain | RmlC-like_jellyroll | 1.79e-03 | 51 | 190 | 4 | IPR014710 | |
| Domain | WH2 | 1.79e-03 | 24 | 190 | 3 | PS51082 | |
| Domain | SANT/Myb | 1.92e-03 | 52 | 190 | 4 | IPR001005 | |
| Domain | DUF3585 | 2.09e-03 | 7 | 190 | 2 | IPR022735 | |
| Domain | DUF3585 | 2.09e-03 | 7 | 190 | 2 | PF12130 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 NES SPIRE2 MYO9A SIPA1L3 MAST2 PRAG1 DENND2B USP31 PTPN3 MAST4 SEC16A GNAS CAMSAP1 CFAP97 RASAL2 LIMA1 OFD1 KIF26B NELFB SORBS1 MICALL1 KIAA1671 VPS13D IGF1R ARHGEF1 KIAA1217 SIPA1L1 MARK4 NEURL1 RAI14 TRAPPC14 PCM1 OTOG | 6.60e-19 | 861 | 199 | 34 | 36931259 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | RBM10 SIPA1L3 ZEB2 SEC16A CAMSAP1 RASAL2 OFD1 NUP88 JMJD1C NCOR2 FAM193A ZNF592 SIPA1L1 SPEN PCM1 RAVER1 | 1.30e-14 | 184 | 199 | 16 | 32908313 |
| Pubmed | 3.25e-14 | 6 | 199 | 6 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 3.25e-14 | 6 | 199 | 6 | 25930072 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPHK2 SPIRE2 TBC1D9B PIEZO1 ARHGAP26 SIPA1L3 ARHGEF11 MAST2 PRAG1 KIAA2013 EPS15L1 SEC16A RIPOR1 CAMSAP1 CRAMP1 OFD1 RTTN TNRC6C MED13L MICALL1 NCOR2 IGF1R MTMR14 ZNF592 MARK4 ZFYVE26 SPEN GGA1 AGRN SOWAHB ELL TJP3 | 4.67e-14 | 1105 | 199 | 32 | 35748872 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 SIPA1L3 TSC1 CTIF ARHGEF11 MAST2 EPS15L1 MAST4 POC5 MINDY4 CAMSAP1 CFAP97 OFD1 NUP88 SORBS1 TNRC6C MICALL1 KIAA1671 MTMR14 WASF2 KIAA1217 SIPA1L1 ENAH GGA1 AGRN ELL PCM1 RAVER1 | 1.04e-13 | 853 | 199 | 28 | 28718761 |
| Pubmed | NES TRAF3 LZTS3 SIPA1L3 TSC1 ARHGEF11 UBN2 ZEB2 EPS15L1 KCNB1 SEC16A BSN CAMSAP1 WASF1 RASAL2 SHANK1 LIMA1 ANK2 HCN3 SORBS1 AKAP12 NCOR2 WASF2 KIAA1217 SIPA1L1 ENAH CDK5RAP2 AGRN PCM1 | 3.11e-13 | 963 | 199 | 29 | 28671696 | |
| Pubmed | MYO9A SIPA1L3 PRUNE1 MAST4 SEC16A CAMSAP1 RASAL2 OFD1 KIF26B KIAA1671 VPS13D FAM193A SIPA1L1 PCM1 | 2.14e-11 | 209 | 199 | 14 | 36779422 | |
| Pubmed | DOCK4 RBM10 TSC1 ZEB2 USP31 TRIL SEC16A NAV3 RIPOR1 TET3 WHRN SORBS1 TNRC6C MED13L SIPA1L1 MARK4 SPEN PLCE1 | 2.86e-11 | 407 | 199 | 18 | 12693553 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | SIPA1L3 CTIF PRAG1 BSN CAMSAP1 WASF1 PPFIA2 PCLO SORBS1 TNRC6C CBLB SIPA1L1 ENAH PCM1 | 3.76e-11 | 218 | 199 | 14 | 33378226 |
| Pubmed | SPATA31A7 SPATA31A6 SPATA31C1 MYO18B SPATA31A3 SPATA31A5 SPATA31A1 | 5.76e-11 | 24 | 199 | 7 | 32212159 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CABLES2 DCAF6 MYO9A SIPA1L3 CTIF UBN2 DENND2B TASOR2 EPS15L1 RIPOR1 GNAS TET3 CRAMP1 NOTCH3 TCF7L2 PPFIA2 TNRC6C JMJD1C KIAA1671 CNNM4 NCOR2 IGF1R KLF7 MICAL2 KIAA1217 ENAH RAI14 ELK3 PNPLA7 GLIS1 PCM1 RAVER1 | 1.16e-10 | 1489 | 199 | 32 | 28611215 |
| Pubmed | RBM10 PDZD7 NACAD AARS2 BSN TET3 CRAMP1 WHRN AKAP12 XIRP2 ENAH RAI14 | 1.17e-08 | 233 | 199 | 12 | 37704626 | |
| Pubmed | NES IL16 LZTS3 MYO9A ARHGAP26 SIPA1L3 TSC1 ARHGEF11 USP31 EPS15L1 SEC16A BSN WASF1 RASAL2 SHANK1 MICAL1 LIMA1 ANK2 PPFIA2 PCLO SORBS1 LRIG1 MICAL2 ARHGEF1 KIAA1217 SIPA1L1 RAI14 PCM1 | 1.45e-08 | 1431 | 199 | 28 | 37142655 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TRAF3 RBM10 SIPA1L3 WASF1 LIMA1 ZNF407 SORBS1 MED13L JMJD1C NCOR2 VPS13D WASF2 KIAA1217 SIPA1L1 ENAH RAI14 ELK3 | 1.54e-08 | 536 | 199 | 17 | 15840001 |
| Pubmed | TRAF3 RBM10 SIPA1L3 WASF1 LIMA1 ZNF407 SORBS1 MED13L JMJD1C NCOR2 VPS13D WASF2 KIAA1217 SIPA1L1 ENAH RAI14 ELK3 | 1.63e-08 | 538 | 199 | 17 | 10512203 | |
| Pubmed | TBC1D9B SIPA1L3 TOGARAM1 CTIF UBN2 USP20 KIAA2013 AARS2 NELFB ZNF407 JMJD1C CNNM4 SETD2 VPS13D ARHGAP28 FHDC1 | 3.02e-08 | 493 | 199 | 16 | 15368895 | |
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 3.83e-08 | 34 | 199 | 6 | 30726710 | |
| Pubmed | BCL9L SIPA1L3 MAST2 SEC16A RASAL2 LIMA1 OFD1 FBF1 NELFB SORBS1 KIAA1671 FAM193A SIPA1L1 TRAPPC14 PCM1 | 5.22e-08 | 446 | 199 | 15 | 24255178 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | LZTS3 PRAG1 GNAS WASF1 RASAL2 SHANK1 ANK2 PPFIA2 PCLO SORBS1 SIPA1L1 ENAH | 9.20e-08 | 281 | 199 | 12 | 28706196 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RBM10 EPS15L1 MSL3 SEC16A RIPOR1 LIMA1 NELFB MICALL1 NCOR2 SETD2 ZNF592 FHOD1 SIPA1L1 ELK3 SPEN KLHDC4 PCM1 RAVER1 | 5.85e-07 | 774 | 199 | 18 | 15302935 |
| Pubmed | 8.93e-07 | 130 | 199 | 8 | 12421765 | ||
| Pubmed | DCAF6 MAST2 MYO18B NOTCH3 ANK2 ZNF407 SORBS1 JMJD1C AKAP12 MTMR14 XIRP2 ZNF592 CDK5RAP2 PLCE1 | 1.22e-06 | 497 | 199 | 14 | 23414517 | |
| Pubmed | 1.83e-06 | 5 | 199 | 3 | 12110185 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RBM10 TSC1 PRUNE1 EPS15L1 SEC16A CAMSAP1 LIMA1 ANK2 NUP88 AKAP12 KIAA1671 SETD2 FAM193A WASF2 KIAA1217 FHOD1 ENAH RAI14 PCM1 | 2.04e-06 | 934 | 199 | 19 | 33916271 |
| Pubmed | DOCK4 IL16 SPIRE2 LZTS3 MAST2 EPS15L1 AARS2 POC5 RASAL2 KIF26B HCN3 NELFB AKAP12 IGF1R CDK5RAP2 OTOG | 2.59e-06 | 689 | 199 | 16 | 36543142 | |
| Pubmed | DOCK4 BCL9L LZTS3 NACAD PRUNE1 EPS15L1 KCNB1 NAV3 BSN CAMSAP1 WASF1 SHANK1 ANK2 PPFIA2 PCLO NUP88 SORBS1 KIAA1217 SIPA1L1 ENAH PCM1 | 2.72e-06 | 1139 | 199 | 21 | 36417873 | |
| Pubmed | TASOR2 PTPN3 EPS15L1 SEC16A CAMSAP1 WASF1 RASAL2 FAT4 NELFB AKAP12 KIAA1671 WASF2 CDK5RAP2 RAI14 SPEN GGA1 PCM1 | 2.77e-06 | 777 | 199 | 17 | 35844135 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SIPA1L3 USP31 PTPN3 EPS15L1 PYCR1 RASAL2 LRP12 RTTN NPDC1 AKAP12 MICALL1 KIAA1671 CNNM4 FHOD1 RAI14 AGRN | 4.43e-06 | 719 | 199 | 16 | 35337019 |
| Pubmed | ARHGAP26 NRROS PYCR1 BSN WASF1 RASAL2 FAT4 SMARCAL1 FBF1 NGDN NCOR2 RNF123 CDK5RAP2 SPEN RAVER1 | 4.63e-06 | 638 | 199 | 15 | 31182584 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TRAF3 TBC1D9B LZTS3 TSC1 TASOR2 PYCR1 NOTCH3 SHANK1 PPFIA2 FBF1 SETD2 SIPA1L1 AGRN RAI2 | 4.84e-06 | 560 | 199 | 14 | 21653829 |
| Pubmed | EPS15L1 KCNB1 BSN ANK2 PPFIA2 PCLO HCN3 SORBS1 SIPA1L1 TRAPPC14 PCM1 | 5.76e-06 | 347 | 199 | 11 | 17114649 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NAB1 UBN2 ZEB2 SEC16A TCF7L2 NUP88 KIAA1671 NCOR2 SUDS3 SPEN | 6.42e-06 | 351 | 199 | 11 | 38297188 |
| Pubmed | 6.94e-06 | 122 | 199 | 7 | 30773093 | ||
| Pubmed | BCL9L TRAF3 RBM10 UBN2 ZEB2 SEC16A LIMA1 TCF7L2 OFD1 NUP88 TNRC6C JMJD1C KIAA1671 NCOR2 ZNF592 SUDS3 RAI14 ELK3 SPEN PCM1 RAI2 MYB RAVER1 | 8.35e-06 | 1429 | 199 | 23 | 35140242 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L SIPA1L3 TOGARAM1 MAST2 MYO18B CAMSAP1 FBF1 JMJD1C NGDN ZNF592 SPEN | 8.36e-06 | 361 | 199 | 11 | 26167880 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 MYO9A TSC1 UBN2 SEC16A GNAS BSN SORBS1 KIAA1671 NCOR2 SETD2 KIAA1217 SPEN PCM1 | 8.41e-06 | 588 | 199 | 14 | 38580884 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.01e-05 | 180 | 199 | 8 | 35198878 | |
| Pubmed | 1.22e-05 | 52 | 199 | 5 | 9455477 | ||
| Pubmed | PIEZO1 ARHGAP26 NACAD MAST4 HPS4 BSN CRAMP1 CFAP97 FBF1 MICALL1 ZNF592 CDK5RAP2 RAI14 | 1.28e-05 | 529 | 199 | 13 | 14621295 | |
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 21144999 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.84e-05 | 256 | 199 | 9 | 33397691 | |
| Pubmed | RBM10 UBN2 PRUNE1 EPS15L1 SEC16A LIMA1 JMJD1C KIAA1671 SETD2 ENAH RAI14 SPEN PCM1 | 1.88e-05 | 549 | 199 | 13 | 38280479 | |
| Pubmed | NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation. | 2.15e-05 | 10 | 199 | 3 | 17101133 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ARHGAP26 EPS15L1 SEC16A RIPOR1 MINDY4 WASF1 RASAL2 WHRN LIMA1 OFD1 NUP88 AKAP12 MICALL1 KIAA1671 CNNM4 NDUFAF4 SIPA1L1 ENAH RAI14 GGA1 RAVER1 | 2.53e-05 | 1321 | 199 | 21 | 27173435 |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 2.63e-05 | 101 | 199 | 6 | 24613305 | |
| Pubmed | ZEB2 SEC16A CAMSAP1 NUP88 JMJD1C KIAA1671 NCOR2 FAM193A ZNF592 RAI14 PCM1 | 3.23e-05 | 418 | 199 | 11 | 34709266 | |
| Pubmed | Newborn adiposity is associated with cord blood DNA methylation at IGF1R and KLF7. | 3.26e-05 | 2 | 199 | 2 | 39165088 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 3.26e-05 | 2 | 199 | 2 | 23403927 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 32697617 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 3.26e-05 | 2 | 199 | 2 | 26793095 | |
| Pubmed | Phosphorylation of WAVE2 by MAP kinases regulates persistent cell migration and polarity. | 3.26e-05 | 2 | 199 | 2 | 18032787 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 16263795 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 37735673 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 20332206 | ||
| Pubmed | Regulation of WAVE1 expression in macrophages at multiple levels. | 3.26e-05 | 2 | 199 | 2 | 18765479 | |
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 3.26e-05 | 2 | 199 | 2 | 21935939 | |
| Pubmed | A gene family of HMG-box transcription factors with homology to TCF-1. | 3.26e-05 | 2 | 199 | 2 | 1741298 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 24577058 | ||
| Pubmed | MYO9A deficiency in motor neurons is associated with reduced neuromuscular agrin secretion. | 3.26e-05 | 2 | 199 | 2 | 29462312 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 26364583 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 24855647 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 3.26e-05 | 2 | 199 | 2 | 25652077 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 30232588 | ||
| Pubmed | Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis. | 3.26e-05 | 2 | 199 | 2 | 30994039 | |
| Pubmed | Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. | 3.26e-05 | 2 | 199 | 2 | 9916915 | |
| Pubmed | Differential regulation of actin microfilaments by human MICAL proteins. | 3.26e-05 | 2 | 199 | 2 | 22331357 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 27321892 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 32493491 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | TSC1 ARHGEF11 SPATA31A6 GRID2IP CCDC187 SORBS1 VPS13D NDUFAF4 IGF1R XIRP2 ZNF592 RAI14 | 3.28e-05 | 497 | 199 | 12 | 36774506 |
| Pubmed | SIPA1L3 TSC1 USP31 PTPN3 SEC16A PYCR1 POC5 WASF1 OFD1 KIAA1671 CNNM4 NCOR2 C1orf226 MTMR14 ENAH CDK5RAP2 RAI14 RAVER1 | 3.72e-05 | 1049 | 199 | 18 | 27880917 | |
| Pubmed | 3.74e-05 | 33 | 199 | 4 | 27414999 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TASOR2 BSN CAMSAP1 TCF7L2 KIAA1671 NCOR2 FAM193A XIRP2 TSHZ1 INAVA SPEN | 4.17e-05 | 430 | 199 | 11 | 35044719 |
| Pubmed | 4.22e-05 | 67 | 199 | 5 | 29254152 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 4.25e-05 | 110 | 199 | 6 | 37219487 | |
| Pubmed | 5.73e-05 | 116 | 199 | 6 | 30804394 | ||
| Pubmed | 6.41e-05 | 14 | 199 | 3 | 16452088 | ||
| Pubmed | 7.98e-05 | 15 | 199 | 3 | 34835087 | ||
| Pubmed | C2cd3 is critical for centriolar distal appendage assembly and ciliary vesicle docking in mammals. | 7.98e-05 | 15 | 199 | 3 | 24469809 | |
| Pubmed | DCAF6 IL16 MAST2 SEC16A PDLIM2 FBF1 KIAA1671 NCOR2 SETD2 C1orf226 ZNF592 SUDS3 SIPA1L1 MARK4 NEURL1 OSMR TCF7L1 PCM1 | 8.20e-05 | 1116 | 199 | 18 | 31753913 | |
| Pubmed | 8.68e-05 | 125 | 199 | 6 | 29467281 | ||
| Pubmed | UBN2 EPS15L1 MSL3 SEC16A CAMSAP1 MED26 WASF1 OFD1 MED13L ZNF592 RAI14 SPEN PCM1 | 9.69e-05 | 645 | 199 | 13 | 25281560 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 17607356 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 21890822 | ||
| Pubmed | Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells. | 9.74e-05 | 3 | 199 | 2 | 15143072 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 25659031 | ||
| Pubmed | In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators. | 9.74e-05 | 3 | 199 | 2 | 24463605 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 21454492 | ||
| Pubmed | Genomic organization and expression profile of the human and mouse WAVE gene family. | 9.74e-05 | 3 | 199 | 2 | 12856283 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 24268649 | ||
| Pubmed | Characterization of the WAVE1 knock-out mouse: implications for CNS development. | 9.74e-05 | 3 | 199 | 2 | 12716942 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 34525377 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 31392276 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 32403323 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 19454037 | ||
| Pubmed | RapGAPs in brain: multipurpose players in neuronal Rap signalling. | 9.74e-05 | 3 | 199 | 2 | 20576033 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 26883496 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 21769917 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 24135282 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 33502684 | ||
| Interaction | YWHAH interactions | DOCK4 NES SPIRE2 MYO9A SIPA1L3 TSC1 MAST2 PRAG1 DENND2B LNP1 USP31 PTPN3 GRID2IP MAST4 AARS2 SEC16A CAMSAP1 WASF1 CFAP97 RASAL2 TICRR LIMA1 OFD1 KIF26B NELFB SORBS1 MICALL1 KIAA1671 VPS13D WASF2 KIAA1217 SIPA1L1 MARK4 RAI14 TRAPPC14 PCM1 OTOG | 1.93e-11 | 1102 | 193 | 37 | int:YWHAH |
| Interaction | YWHAG interactions | DOCK4 TRAF3 SPIRE2 MYO9A SIPA1L3 TSC1 MAST2 PRAG1 DENND2B LNP1 USP31 PTPN3 GRID2IP MAST4 NFATC2 SEC16A GNAS CAMSAP1 C2orf49 WASF1 CFAP97 RASAL2 TICRR LIMA1 KIF26B NELFB SORBS1 MICALL1 KIAA1671 VPS13D IGF1R ARHGEF1 WASF2 SIPA1L1 MARK4 RAI14 TRAPPC14 PCM1 OTOG | 4.32e-11 | 1248 | 193 | 39 | int:YWHAG |
| Interaction | YWHAB interactions | DOCK4 SPIRE2 MYO9A SIPA1L3 TSC1 MAST2 DENND2B LNP1 USP31 PTPN3 GRID2IP MAST4 NFATC2 CAMSAP1 WASF1 RASAL2 TICRR LIMA1 KIF26B NELFB SORBS1 MICALL1 KIAA1671 VPS13D IGF1R WASF2 SIPA1L1 MARK4 RAI14 PCM1 OTOG | 9.64e-09 | 1014 | 193 | 31 | int:YWHAB |
| Interaction | YWHAE interactions | SPIRE2 MYO9A RBM10 SIPA1L3 TSC1 MAST2 PRAG1 DENND2B LNP1 USP31 PTPN3 MAST4 AARS2 NFATC2 MINDY4 CAMSAP1 C2orf49 WASF1 RASAL2 TICRR LIMA1 KIF26B NELFB SORBS1 MICALL1 KIAA1671 ZNF750 NCOR2 IGF1R SIPA1L1 MARK4 RAI14 AGRN PCM1 OTOG | 1.00e-08 | 1256 | 193 | 35 | int:YWHAE |
| Interaction | PXN interactions | DOCK4 SIPA1L3 PRAG1 SEC16A PYCR1 CAMSAP1 WHRN OFD1 NUP88 SORBS1 MICALL1 KIAA1671 IGF1R KIAA1217 CDK5RAP2 REPS2 | 1.50e-07 | 334 | 193 | 16 | int:PXN |
| Interaction | TOP3B interactions | SPHK2 SPIRE2 TBC1D9B PIEZO1 ARHGAP26 SIPA1L3 CTIF ARHGEF11 MAST2 PRAG1 KIAA2013 EPS15L1 ANOS1 SEC16A RIPOR1 GNAS CAMSAP1 CRAMP1 LIMA1 OFD1 RTTN TNRC6C MED13L MICALL1 NCOR2 IGF1R MTMR14 ZNF592 MARK4 ZFYVE26 SPEN GGA1 AGRN SOWAHB ELL TJP3 | 1.57e-07 | 1470 | 193 | 36 | int:TOP3B |
| Interaction | SYNE3 interactions | DOCK4 SIPA1L3 TOGARAM1 TSC1 SEC16A CAMSAP1 OFD1 FBF1 NUP88 SORBS1 TNRC6C KIAA1671 NCOR2 FAM193A KIAA1217 SIPA1L1 CDK5RAP2 RAVER1 | 2.94e-07 | 444 | 193 | 18 | int:SYNE3 |
| Interaction | YWHAZ interactions | SPIRE2 MYO9A SIPA1L3 TSC1 MAST2 DENND2B LNP1 USP31 PTPN3 MAST4 NFATC2 CAMSAP1 C2orf49 WASF1 RASAL2 TICRR LIMA1 KIF26B PPFIA2 NELFB SORBS1 MICALL1 KIAA1671 VPS13D IGF1R FHOD1 SIPA1L1 MARK4 ENAH CDK5RAP2 RAI14 PCM1 OTOG | 3.49e-07 | 1319 | 193 | 33 | int:YWHAZ |
| Interaction | BICD1 interactions | DOCK4 NES SIPA1L3 POC5 MINDY4 CFAP97 OFD1 SORBS1 TNRC6C KIAA1671 WASF2 GGA1 PCM1 | 9.15e-07 | 250 | 193 | 13 | int:BICD1 |
| Interaction | YWHAQ interactions | SPIRE2 MYO9A SIPA1L3 TSC1 MAST2 DENND2B LNP1 USP31 PTPN3 MAST4 AARS2 NFATC2 FGR CAMSAP1 C2orf49 RASAL2 TICRR LIMA1 KIF26B NELFB SORBS1 KIAA1671 VPS13D IGF1R WASF2 SIPA1L1 RAI14 PCM1 OTOG | 9.62e-07 | 1118 | 193 | 29 | int:YWHAQ |
| Interaction | CEP135 interactions | LZTS3 SIPA1L3 TOGARAM1 SEC16A CAMSAP1 OFD1 FBF1 RTTN TNRC6C KIAA1671 SIPA1L1 CDK5RAP2 PCM1 | 2.34e-06 | 272 | 193 | 13 | int:CEP135 |
| Interaction | TRIM37 interactions | TRAF3 RBM10 SIPA1L3 ZEB2 SEC16A GNAS CAMSAP1 RASAL2 LIMA1 OFD1 NUP88 JMJD1C NCOR2 FAM193A ZNF592 SIPA1L1 CDK5RAP2 SPEN PCM1 RAVER1 | 2.89e-06 | 630 | 193 | 20 | int:TRIM37 |
| Interaction | BICD2 interactions | DOCK4 SIPA1L3 MAST2 MAST4 POC5 CAMSAP1 NUP88 CCDC187 SORBS1 MICALL1 KIAA1671 MTMR14 WASF2 KIAA1217 ENAH PCM1 | 3.69e-06 | 426 | 193 | 16 | int:BICD2 |
| Interaction | CLTA interactions | NES SIPA1L3 EPS15L1 MAST4 SEC16A CFAP97 LIMA1 TCF7L2 NUP88 TNRC6C ZNF692 KIAA1671 C1orf226 GGA1 | 7.75e-06 | 351 | 193 | 14 | int:CLTA |
| Interaction | PFN1 interactions | DOCK4 MYO9A TSC1 ARHGEF11 GRID2IP SEC16A WASF1 ANK2 PCLO KIAA1671 RNF123 ARHGEF1 WASF2 KIAA1217 FHOD1 ENAH ELL | 8.63e-06 | 509 | 193 | 17 | int:PFN1 |
| Interaction | CTBP1 interactions | DCAF6 ZEB2 NFATC2 SEC16A TCF7L2 OFD1 PCLO FBF1 ZNF750 NCOR2 IGF1R TSHZ1 ELK3 SPEN RAI2 | 9.13e-06 | 406 | 193 | 15 | int:CTBP1 |
| Interaction | GSK3A interactions | DCAF6 MYO9A SIPA1L3 ARHGEF11 PRUNE1 MAST4 SEC16A CAMSAP1 RASAL2 OFD1 KIF26B KIAA1671 VPS13D FAM193A SIPA1L1 PCM1 | 1.08e-05 | 464 | 193 | 16 | int:GSK3A |
| Interaction | DYRK1B interactions | 2.72e-05 | 91 | 193 | 7 | int:DYRK1B | |
| Interaction | AGAP2 interactions | 3.63e-05 | 210 | 193 | 10 | int:AGAP2 | |
| Interaction | PTK2 interactions | ARHGAP26 TSC1 NACAD MAST4 KCNB1 FGR MICAL1 OFD1 SORBS1 CBLB IGF1R FAM193A | 5.46e-05 | 315 | 193 | 12 | int:PTK2 |
| Interaction | DCAF7 interactions | DCAF6 TRAF3 LZTS3 EPS15L1 NFATC2 DMAC1 SMARCAL1 KIAA1671 ZNF750 MARK4 ENAH CDK5RAP2 SOWAHB | 5.79e-05 | 368 | 193 | 13 | int:DCAF7 |
| Interaction | CEP72 interactions | 7.70e-05 | 107 | 193 | 7 | int:CEP72 | |
| Interaction | TNIK interactions | NES LZTS3 TSC1 UBN2 ZEB2 WASF1 SHANK1 ANK2 NCOR2 KIAA1217 SIPA1L1 AGRN PCM1 | 8.22e-05 | 381 | 193 | 13 | int:TNIK |
| Interaction | SHANK3 interactions | BCL9L NES TRAF3 LZTS3 TSC1 TASOR2 CAMSAP1 WASF1 NOTCH3 SHANK1 ANK2 NUP88 SETD2 XIRP2 WASF2 | 9.11e-05 | 496 | 193 | 15 | int:SHANK3 |
| Interaction | LATS1 interactions | RBM10 SIPA1L3 MAST2 SEC16A OFD1 TNRC6C KIAA1671 FAM193A MTMR14 XIRP2 KIAA1217 SIPA1L1 CDK5RAP2 PCM1 | 9.21e-05 | 440 | 193 | 14 | int:LATS1 |
| Interaction | STIL interactions | SIPA1L3 SEC16A OFD1 RTTN TNRC6C FAM193A KIAA1217 CDK5RAP2 PCM1 | 9.31e-05 | 190 | 193 | 9 | int:STIL |
| Interaction | ICE2 interactions | 9.62e-05 | 77 | 193 | 6 | int:ICE2 | |
| Interaction | LZTS2 interactions | LZTS3 MYO9A SIPA1L3 TSC1 PTPN3 SEC16A OFD1 FBF1 CCDC187 SORBS1 TNRC6C KIAA1671 KIAA1217 SIPA1L1 RAVER1 | 1.29e-04 | 512 | 193 | 15 | int:LZTS2 |
| Interaction | CEP128 interactions | LZTS3 POC5 CAMSAP1 CFAP97 RASAL2 OFD1 FBF1 SORBS1 KIAA1671 SIPA1L1 PCM1 | 1.43e-04 | 297 | 193 | 11 | int:CEP128 |
| Interaction | ODF2 interactions | 1.45e-04 | 158 | 193 | 8 | int:ODF2 | |
| Interaction | KCTD13 interactions | NES IL16 LZTS3 MYO9A ARHGAP26 SIPA1L3 TSC1 ARHGEF11 USP31 EPS15L1 SEC16A BSN WASF1 RASAL2 SHANK1 MICAL1 LIMA1 ANK2 PPFIA2 PCLO SORBS1 LRIG1 MICAL2 ARHGEF1 KIAA1217 SIPA1L1 RAI14 PCM1 | 1.56e-04 | 1394 | 193 | 28 | int:KCTD13 |
| Interaction | CNTROB interactions | 2.03e-04 | 166 | 193 | 8 | int:CNTROB | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 9.51e-05 | 325 | 199 | 8 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 1.19e-04 | 250 | 199 | 7 | chrXp22 | |
| Cytoband | Xp22 | 1.72e-04 | 25 | 199 | 3 | Xp22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 5.15e-04 | 8 | 199 | 2 | chr9q12 | |
| GeneFamily | PDZ domain containing | IL16 SIPA1L3 PDZD7 ARHGEF11 MAST2 PTPN3 GRID2IP MAST4 PDLIM2 SHANK1 WHRN PCLO SIPA1L1 TJP3 | 9.31e-13 | 152 | 116 | 14 | 1220 |
| GeneFamily | LIM domain containing | 2.09e-06 | 59 | 116 | 6 | 1218 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.11e-04 | 15 | 116 | 3 | 26 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 2.43e-04 | 4 | 116 | 2 | 1244 | |
| GeneFamily | Ankyrin repeat domain containing | 9.55e-04 | 242 | 116 | 7 | 403 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 2.59e-07 | 85 | 197 | 8 | M10575 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 TOGARAM1 CTIF MAST2 DENND2B ZEB2 NAV3 WASF1 TCF7L2 MED13L CBLB NCOR2 SETD2 IGF1R FAM193A KLF7 LRIG1 MICAL2 SIPA1L1 OSMR SPEN PLCE1 | 5.60e-07 | 856 | 197 | 22 | M4500 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE | TBC1D9B GGN SIPA1L3 NAB1 NRROS EPS15L1 MED26 C2orf49 SHANK1 MED13L JMJD1C KLF7 MICAL2 ISG20L2 | 8.44e-07 | 368 | 197 | 14 | M41100 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | ARHGAP26 ZEB2 MAST4 RIPOR1 LIMA1 TCF7L2 SORBS1 JMJD1C AKAP12 KLF7 RAI14 OSMR | 2.63e-06 | 295 | 197 | 12 | M39121 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 3.38e-06 | 84 | 197 | 7 | M13008 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 3.96e-06 | 86 | 197 | 7 | M39247 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | NES SIDT1 TRIL PTPN3 GRID2IP NFATC2 GNAS PDLIM2 PAQR9 TICRR FAT4 TCF7L2 KIF26B ZIC5 KIAA1217 SP5 ARHGAP28 INAVA FHDC1 OSMR GLIS1 SOWAHB MYB | 6.58e-06 | 1074 | 197 | 23 | M1941 |
| Coexpression | GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN | 1.64e-05 | 193 | 197 | 9 | M9712 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.10e-05 | 199 | 197 | 9 | M5893 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 2.18e-05 | 200 | 197 | 9 | M6583 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | CABLES2 ACAP1 TRAF3 ARHGAP26 TNRC6C MED13L CBLB JMJD1C MTMR14 | 2.18e-05 | 200 | 197 | 9 | M7839 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | SPIRE2 LZTS3 ARHGEF11 NACAD FCGBP NALCN C2CD4D PDLIM2 WHRN RTTN NPDC1 MICALL1 KIAA1671 CNNM4 ZNF750 LRIG1 PNPLA7 REPS2 | 2.46e-05 | 775 | 197 | 18 | M45713 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | DOCK4 TBC1D9B GGN TICAM1 SIPA1L3 NAB1 CTIF NRROS RIPOR1 MED26 C2orf49 WASF1 TET3 NOTCH3 SHANK1 MED13L JMJD1C CNNM4 NCOR2 MTMR14 MICAL2 SIPA1L1 ISG20L2 ELL | 2.47e-05 | 1250 | 197 | 24 | M41099 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK4 LZTS3 NUTM2A PDZD7 UBN2 MAST4 NALCN NAV3 BSN WASF1 RASAL2 PDE11A LRP12 ANK2 PPFIA2 PCLO HCN3 NPDC1 SORBS1 TNRC6C MED13L KLF7 | 3.26e-05 | 1106 | 197 | 22 | M39071 |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | KATNAL2 DENND2B ZEB2 NAV3 PYCR1 LIMA1 ANK2 SMARCAL1 RTTN ZFYVE26 RAI14 TRAPPC14 TJP3 | 3.84e-05 | 449 | 197 | 13 | M2013 |
| Coexpression | HEVNER_CORTEX_ROSTRAL_VENTRICULAR_ZONE | 7.28e-05 | 30 | 197 | 4 | MM449 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 8.22e-05 | 137 | 197 | 7 | M39241 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DOCK4 TOGARAM1 PTPN3 MAST4 NAV3 MED13L CBLB KLF7 MICAL2 SPEN | 9.74e-05 | 300 | 197 | 10 | M8702 |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | KATNAL2 DENND2B ZEB2 NAV3 PYCR1 LIMA1 ANK2 SMARCAL1 RTTN ZFYVE26 RAI14 TRAPPC14 TJP3 | 1.07e-04 | 497 | 197 | 13 | MM863 |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | ARHGAP26 RASAL2 LIMA1 TCF7L2 NPDC1 JMJD1C AKAP12 KLF7 OSMR TCF7L1 | 1.09e-04 | 304 | 197 | 10 | M39113 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | DOCK4 NAB1 NRROS C2orf49 TET3 SHANK1 MED13L NCOR2 KLF7 MTMR14 MICAL2 SPEN | 1.20e-04 | 435 | 197 | 12 | M41115 |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.28e-04 | 197 | 197 | 8 | M8983 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH1_UP | 1.28e-04 | 197 | 197 | 8 | M5532 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP | 1.38e-04 | 199 | 197 | 8 | M9038 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | MAST4 NFATC2 RIPOR1 GNAS LIMA1 NPDC1 JMJD1C AKAP12 ELK3 TCF7L1 | 1.38e-04 | 313 | 197 | 10 | M39128 |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP | 1.42e-04 | 200 | 197 | 8 | M3850 | |
| Coexpression | HALLMARK_ESTROGEN_RESPONSE_EARLY | 1.42e-04 | 200 | 197 | 8 | M5906 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.42e-04 | 200 | 197 | 8 | M9002 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | LZTS3 MYO9A TICAM1 TSC1 ZEB2 RIPOR1 RASAL2 TCF7L2 SORBS1 MED13L CBLB JMJD1C CNNM4 SETD2 IGF1R TCF7L1 ELL | 1.69e-04 | 822 | 197 | 17 | M6782 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.12e-04 | 212 | 197 | 8 | M39221 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | DOCK4 NES ARHGAP26 DENND2B RASAL2 FAT4 SORBS1 KIAA1671 IGF1R KLF7 KIAA1217 | 1.05e-09 | 190 | 199 | 11 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PIEZO1 LINC01558 USP31 NALCN GNAS PCLO AKAP12 UBAP1L RAI14 ELK3 | 1.68e-08 | 192 | 199 | 10 | 5388f3115ab285f3f3001af1d71543ed64b9e044 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PIEZO1 LINC01558 USP31 NALCN GNAS PCLO AKAP12 UBAP1L RAI14 ELK3 | 1.77e-08 | 193 | 199 | 10 | ef007b736da56529ec628fc3df86a335e7ec3f18 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-07 | 181 | 199 | 9 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-07 | 181 | 199 | 9 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-07 | 183 | 199 | 9 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-07 | 183 | 199 | 9 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP26 PRAG1 DENND2B NALCN NFATC2 SORBS1 AKAP12 MICAL2 OSMR | 1.52e-07 | 184 | 199 | 9 | d2bf0135eb56bb410997dccea39c5ede88a0617f |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES ARHGAP26 DENND2B RASAL2 NPDC1 SORBS1 KIAA1671 KLF7 KIAA1217 | 1.90e-07 | 189 | 199 | 9 | b6b4da51bc7f2c13a2f940540fdc61027d084835 |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | DENND2B MAST4 LRIG1 MICAL2 KIAA1217 RAI14 MAP3K13 OSMR TCF7L1 | 2.17e-07 | 192 | 199 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 176 | 199 | 8 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 176 | 199 | 8 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-06 | 177 | 199 | 8 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 178 | 199 | 8 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-06 | 179 | 199 | 8 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.55e-06 | 180 | 199 | 8 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 183 | 199 | 8 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 184 | 199 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 184 | 199 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.83e-06 | 184 | 199 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 184 | 199 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.15e-06 | 188 | 199 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.23e-06 | 189 | 199 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.32e-06 | 190 | 199 | 8 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.32e-06 | 190 | 199 | 8 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-06 | 191 | 199 | 8 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 191 | 199 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-06 | 191 | 199 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-06 | 191 | 199 | 8 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 191 | 199 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 192 | 199 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 192 | 199 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-06 | 193 | 199 | 8 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-06 | 193 | 199 | 8 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 196 | 199 | 8 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.92e-06 | 196 | 199 | 8 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 197 | 199 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 198 | 199 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 198 | 199 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 199 | 199 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.40e-06 | 200 | 199 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.17e-06 | 161 | 199 | 7 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 9.22e-06 | 164 | 199 | 7 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-05 | 170 | 199 | 7 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 170 | 199 | 7 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 170 | 199 | 7 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 172 | 199 | 7 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 175 | 199 | 7 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.63e-05 | 179 | 199 | 7 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 1.63e-05 | 179 | 199 | 7 | 3dc929a10381b7d86650c6cd8f354892fe1d93e7 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 1.63e-05 | 179 | 199 | 7 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.69e-05 | 180 | 199 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.83e-05 | 122 | 199 | 6 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 183 | 199 | 7 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.88e-05 | 183 | 199 | 7 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | Mild/Remission-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.94e-05 | 184 | 199 | 7 | 3d4864605c812862cf8926e02370eea3b8ccf32f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.01e-05 | 185 | 199 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.01e-05 | 185 | 199 | 7 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 185 | 199 | 7 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 185 | 199 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 186 | 199 | 7 | 1094c7140131454b2583200e1c01e81ccab3db23 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.08e-05 | 186 | 199 | 7 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.16e-05 | 187 | 199 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.23e-05 | 188 | 199 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 188 | 199 | 7 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.31e-05 | 189 | 199 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 190 | 199 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 190 | 199 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.39e-05 | 190 | 199 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 190 | 199 | 7 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.47e-05 | 191 | 199 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-05 | 191 | 199 | 7 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.47e-05 | 191 | 199 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.55e-05 | 192 | 199 | 7 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-05 | 192 | 199 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.55e-05 | 192 | 199 | 7 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 192 | 199 | 7 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.64e-05 | 193 | 199 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-05 | 193 | 199 | 7 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-05 | 193 | 199 | 7 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-05 | 193 | 199 | 7 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.64e-05 | 193 | 199 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 193 | 199 | 7 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 194 | 199 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-05 | 194 | 199 | 7 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 194 | 199 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 194 | 199 | 7 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.73e-05 | 194 | 199 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-05 | 194 | 199 | 7 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 194 | 199 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 195 | 199 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.82e-05 | 195 | 199 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 195 | 199 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.82e-05 | 195 | 199 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 195 | 199 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 196 | 199 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-05 | 196 | 199 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 196 | 199 | 7 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 196 | 199 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 196 | 199 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-04 | 50 | 103 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | SPHK2 USP20 HPS4 SMARCAL1 VPS13D KLF7 ARHGEF1 FHOD1 MARK4 MYB | 4.25e-06 | 185 | 193 | 10 | 4327_DN |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | DOCK4 MAST2 MAST4 MSL3 WNT10B MICALL1 SETD2 KLF7 LRIG1 MARK4 | 4.90e-06 | 188 | 193 | 10 | 2854_UP |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | TRAF3 SIDT1 MAST4 MSL3 RIPOR1 AKAP12 CNNM4 MICAL2 CDK5RAP2 REPS2 | 6.18e-06 | 193 | 193 | 10 | 1644_DN |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | SPHK2 RBM10 ARHGEF11 WASF1 NOTCH3 RASAL2 WHRN MARK4 AGRN ELL | 6.18e-06 | 193 | 193 | 10 | 3262_UP |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | CTIF TLR8 KCNB1 GNAS RASAL2 WHRN MICAL1 KIF26B IGF1R MAP3K13 | 7.09e-06 | 196 | 193 | 10 | 6027_UP |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.41e-06 | 197 | 193 | 10 | 4787_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | TRAF3 LZTS3 PRUNE1 HPS4 MSL3 PARPBP SMARCAL1 CNNM4 SIPA1L1 TRAPPC14 | 7.41e-06 | 197 | 193 | 10 | 5477_DN |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | LZTS3 SIPA1L3 MAST4 WHRN ZNF407 NCOR2 VPS13D ARHGEF1 SPEN RAI2 | 7.75e-06 | 198 | 193 | 10 | 4762_DN |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | LZTS3 SIPA1L3 MAST2 PRUNE1 HPS4 VPS13D ZNF592 ZFYVE26 ELL TJP3 | 8.10e-06 | 199 | 193 | 10 | 5466_DN |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | TBC1D9B LZTS3 ARHGAP26 ARHGEF11 MAST2 HPS4 CAMSAP1 TCF7L2 VPS13D PCM1 | 8.46e-06 | 200 | 193 | 10 | 7129_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.68e-05 | 172 | 193 | 9 | 3979_UP | |
| Drug | SAHA; Up 200; 10uM; MCF7; HT_HG-U133A | 2.41e-05 | 180 | 193 | 9 | 6939_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.41e-05 | 180 | 193 | 9 | 6064_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.51e-05 | 181 | 193 | 9 | 7453_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.84e-05 | 191 | 193 | 9 | 1057_DN | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.00e-05 | 192 | 193 | 9 | 3318_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 4.33e-05 | 194 | 193 | 9 | 6616_DN | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | TICAM1 RIPOR1 RASAL2 VPS13D SIPA1L1 MARK4 NEURL1 TRAPPC14 ELL | 4.33e-05 | 194 | 193 | 9 | 6072_DN |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 4.33e-05 | 194 | 193 | 9 | 1239_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 4.33e-05 | 194 | 193 | 9 | 4320_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.51e-05 | 195 | 193 | 9 | 4817_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A | TBC1D9B LZTS3 ARHGAP26 EPS15L1 TCF7L2 NGDN VPS13D SIPA1L1 AGRN | 4.51e-05 | 195 | 193 | 9 | 2727_DN |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | SPHK2 TICAM1 ARHGAP26 CTIF EPS15L1 KCNB1 MED13L TRAPPC14 PLCE1 | 4.51e-05 | 195 | 193 | 9 | 6245_UP |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | LZTS3 SIPA1L3 MAST2 RASAL2 MICALL1 SETD2 RNF123 SIPA1L1 OSMR | 4.69e-05 | 196 | 193 | 9 | 2834_DN |
| Drug | Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A | 4.69e-05 | 196 | 193 | 9 | 3878_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | ACAP1 RIPOR1 MED13L VPS13D ARHGEF1 MARK4 ZFYVE26 KLHDC4 GGA1 | 4.69e-05 | 196 | 193 | 9 | 1156_DN |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.88e-05 | 197 | 193 | 9 | 5436_DN | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 4.88e-05 | 197 | 193 | 9 | 2839_UP | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A | DOCK4 ZNF549 RIPOR1 CAMSAP1 WHRN CNNM4 VPS13D MICAL2 SIPA1L1 | 4.88e-05 | 197 | 193 | 9 | 2156_UP |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.88e-05 | 197 | 193 | 9 | 4745_DN | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 5.08e-05 | 198 | 193 | 9 | 6450_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 5.08e-05 | 198 | 193 | 9 | 4729_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; HL60; HT_HG-U133A | 5.08e-05 | 198 | 193 | 9 | 2447_DN | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 5.28e-05 | 199 | 193 | 9 | 5617_DN | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A | 5.28e-05 | 199 | 193 | 9 | 2135_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.28e-05 | 199 | 193 | 9 | 4634_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 5.49e-05 | 200 | 193 | 9 | 3322_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; HL60; HG-U133A | 5.49e-05 | 200 | 193 | 9 | 1757_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.18e-04 | 173 | 193 | 8 | 4112_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-04 | 174 | 193 | 8 | 5260_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.23e-04 | 174 | 193 | 8 | 5231_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.28e-04 | 175 | 193 | 8 | 7236_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.39e-04 | 177 | 193 | 8 | 3395_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.44e-04 | 178 | 193 | 8 | 4388_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.50e-04 | 179 | 193 | 8 | 5903_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.62e-04 | 181 | 193 | 8 | 5987_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.68e-04 | 182 | 193 | 8 | 1043_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 1.74e-04 | 183 | 193 | 8 | 6925_DN | |
| Drug | trichostatin A; Up 200; 0.1uM; MCF7; HG-U133A | 1.95e-04 | 186 | 193 | 8 | 332_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.95e-04 | 186 | 193 | 8 | 6891_UP | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.09e-04 | 188 | 193 | 8 | 7466_UP | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.17e-04 | 189 | 193 | 8 | 1285_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 2.17e-04 | 189 | 193 | 8 | 1168_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.25e-04 | 190 | 193 | 8 | 7546_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.25e-04 | 190 | 193 | 8 | 4362_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | 2.42e-04 | 192 | 193 | 8 | 6639_DN | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 2.42e-04 | 192 | 193 | 8 | 3087_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.50e-04 | 193 | 193 | 8 | 5588_DN | |
| Drug | carbamazepine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.50e-04 | 193 | 193 | 8 | 835_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.50e-04 | 193 | 193 | 8 | 7447_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 2.59e-04 | 194 | 193 | 8 | 1670_DN | |
| Drug | Imidurea [39236-46-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.59e-04 | 194 | 193 | 8 | 5062_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.59e-04 | 194 | 193 | 8 | 5932_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.59e-04 | 194 | 193 | 8 | 4360_UP | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 2.59e-04 | 194 | 193 | 8 | 3674_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 5325_UP | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 6845_DN | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 4533_DN | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; PC3; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 6283_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A | 2.68e-04 | 195 | 193 | 8 | 2004_DN | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 5427_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 1292_UP | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 2942_UP | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 2230_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 3860_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 2426_UP | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 6067_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 3530_DN | |
| Drug | Florfenicol [73231-34-2]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 3083_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 4971_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.68e-04 | 195 | 193 | 8 | 4124_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 4482_UP | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 2248_DN | |
| Drug | DO 897/99; Up 200; 8.2uM; HL60; HG-U133A | 2.78e-04 | 196 | 193 | 8 | 1728_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 3187_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 7269_UP | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 7139_DN | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; HL60; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 3134_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 4540_DN | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 5331_UP | |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 7479_UP | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 4227_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 1708_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 1684_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.78e-04 | 196 | 193 | 8 | 5533_UP | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 193 | 8 | 4485_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.87e-04 | 197 | 193 | 8 | 5819_DN | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 193 | 8 | 6412_DN | |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 193 | 8 | 7459_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 193 | 8 | 7011_DN | |
| Disease | Malignant neoplasm of breast | ACAP1 TBC1D9B TICAM1 CTIF ZEB2 CLCN1 NOTCH3 RASAL2 MICAL1 ANK2 SMARCAL1 WNT10B SORBS1 AKAP12 MICALL1 CNNM4 SETD2 IGF1R SIPA1L1 ZFYVE26 ELK3 MAP3K13 REPS2 SPEN GGA1 TCF7L1 | 4.47e-09 | 1074 | 186 | 26 | C0006142 |
| Disease | diastolic blood pressure, systolic blood pressure | ACAP1 TRAF3 MYO9A CTIF DENND2B KCNB1 SEC16A PDE11A ANK2 CBLB KIAA1671 MALRD1 KLF7 LRIG1 ZIC5 TCF7L1 ELL PCM1 | 2.81e-07 | 670 | 186 | 18 | EFO_0006335, EFO_0006336 |
| Disease | myeloid white cell count | ACAP1 SPHK2 PIEZO1 ARHGAP26 CTIF MAST2 DENND2B EPS15L1 RASAL2 LIMA1 TCF7L2 JMJD1C SETD2 MICAL2 MARK4 ENAH RAI14 GGA1 TCF7L1 PLCE1 | 2.17e-06 | 937 | 186 | 20 | EFO_0007988 |
| Disease | obesity (implicated_via_orthology) | 9.70e-06 | 215 | 186 | 9 | DOID:9970 (implicated_via_orthology) | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 1.74e-05 | 25 | 186 | 4 | EFO_0010556 | |
| Disease | serum gamma-glutamyl transferase measurement | TRAF3 MYO9A SIPA1L3 ARHGEF11 DENND2B LINC01558 TRIL PTPN3 CBLB JMJD1C NCOR2 SETD2 IGF1R ENAH TSHZ1 CCDC171 PLCE1 TJP3 | 2.11e-05 | 914 | 186 | 18 | EFO_0004532 |
| Disease | total blood protein measurement | CABLES2 TRAF3 ARHGAP26 PTPN3 EPS15L1 SEC16A TCF7L2 NCOR2 SETD2 MARK4 TCF7L1 PLCE1 | 3.06e-05 | 449 | 186 | 12 | EFO_0004536 |
| Disease | uric acid measurement | MYO9A ARHGAP26 SIPA1L3 NFATC2 MINDY4 GNAS FAT4 TCF7L2 ANKRD33 IGF1R LRIG1 MARK4 RAI14 GLIS1 | 3.57e-05 | 610 | 186 | 14 | EFO_0004761 |
| Disease | hyperuricemia | 5.42e-05 | 33 | 186 | 4 | EFO_0009104 | |
| Disease | immature platelet count | 5.86e-05 | 106 | 186 | 6 | EFO_0803544 | |
| Disease | creatinine measurement | SPIRE2 SIPA1L3 MAST2 USP20 PTPN3 GNAS BSN TCF7L2 KIF26B PPFIA2 CBLB RNF123 IGF1R LRIG1 ZNF592 PNPLA7 REPS2 ELL | 6.33e-05 | 995 | 186 | 18 | EFO_0004518 |
| Disease | pulse pressure measurement | ARHGAP26 NAB1 MAST2 NFATC2 POC5 FGR NOTCH3 DMAC1 PAQR9 TCF7L2 ANK2 MED13L KCNH4 MALRD1 FAM193A LRIG1 WASF2 KIAA1217 TCF7L1 ELL PCM1 PLCE1 | 7.12e-05 | 1392 | 186 | 22 | EFO_0005763 |
| Disease | platelet crit | PIEZO1 ARHGEF11 DENND2B MAST4 NAV3 PDLIM2 NOTCH3 RASAL2 RTTN ZNF407 JMJD1C IGF1R MARK4 ISG20L2 MYB PLCE1 RAVER1 | 1.19e-04 | 952 | 186 | 17 | EFO_0007985 |
| Disease | atrial fibrillation | ARHGAP26 MYO18B CRAMP1 JMJD1C NCOR2 IGF1R LRIG1 NEURL1 SPEN PCM1 | 1.32e-04 | 371 | 186 | 10 | EFO_0000275 |
| Disease | prostate carcinoma | SIPA1L3 SIDT1 MAST2 TASOR2 MAST4 BSN PARPBP CRAMP1 DMAC1 TCF7L2 ANK2 IGF1R KLF7 TSHZ1 SPEN SOWAHB | 1.78e-04 | 891 | 186 | 16 | EFO_0001663 |
| Disease | hematocrit | MYO9A PIEZO1 ARHGAP26 CTIF MAST2 DENND2B BSN TCF7L2 SORBS1 NCOR2 ANKRD33 KLF7 MARK4 RAI14 OSMR ELL MYB | 2.41e-04 | 1011 | 186 | 17 | EFO_0004348 |
| Disease | Neurodevelopmental Disorders | 3.13e-04 | 93 | 186 | 5 | C1535926 | |
| Disease | Herpetic Acute Necrotizing Encephalitis | 3.90e-04 | 5 | 186 | 2 | C0001338 | |
| Disease | Usher Syndrome, Type II | 3.90e-04 | 5 | 186 | 2 | C1568249 | |
| Disease | Renal glomerular disease | 3.98e-04 | 23 | 186 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.98e-04 | 23 | 186 | 3 | C4521256 | |
| Disease | hip bone mineral density, hip bone size | 4.35e-04 | 56 | 186 | 4 | EFO_0004844, EFO_0007702 | |
| Disease | red blood cell density measurement | MYO9A PIEZO1 CTIF ARHGEF11 MAST2 DENND2B ZEB2 PTPN3 TCF7L2 SORBS1 JMJD1C KLF7 MARK4 RAI14 MYB | 4.90e-04 | 880 | 186 | 15 | EFO_0007978 |
| Disease | migraine disorder, diastolic blood pressure | 5.12e-04 | 25 | 186 | 3 | EFO_0006336, MONDO_0005277 | |
| Disease | hair colour measurement | IL16 SPIRE2 PIEZO1 TYR DMAC1 AKAP12 ZNF750 RAI14 CCDC171 KLHDC4 ELL MYB | 5.64e-04 | 615 | 186 | 12 | EFO_0007822 |
| Disease | Symptomatic Infantile Spasms | 5.83e-04 | 6 | 186 | 2 | C0393699 | |
| Disease | Cryptogenic Infantile Spasms | 5.83e-04 | 6 | 186 | 2 | C0393698 | |
| Disease | persistent Staphylococcus aureus carrier status | 5.83e-04 | 6 | 186 | 2 | EFO_0007757 | |
| Disease | Herpetic meningoencephalitis | 5.83e-04 | 6 | 186 | 2 | C0019385 | |
| Disease | Hypsarrhythmia | 5.83e-04 | 6 | 186 | 2 | C0684276 | |
| Disease | Salaam Seizures | 5.83e-04 | 6 | 186 | 2 | C1527366 | |
| Disease | Nodding spasm | 5.83e-04 | 6 | 186 | 2 | C0546878 | |
| Disease | spasmus nutans | 5.83e-04 | 6 | 186 | 2 | C1527306 | |
| Disease | Jackknife Seizures | 5.83e-04 | 6 | 186 | 2 | C0553558 | |
| Disease | myelofibrosis (implicated_via_orthology) | 5.83e-04 | 6 | 186 | 2 | DOID:4971 (implicated_via_orthology) | |
| Disease | cortical thickness | SPIRE2 SIDT1 MAST2 MAST4 NAV3 TCF7L2 SMARCAL1 JMJD1C MICALL1 VPS13D IGF1R MALRD1 CDK5RAP2 OSMR CCDC171 ELL PLCE1 | 7.17e-04 | 1113 | 186 | 17 | EFO_0004840 |
| Disease | hip bone size | 7.67e-04 | 65 | 186 | 4 | EFO_0004844 | |
| Disease | mean platelet volume | NAB1 SIDT1 DENND2B MAST4 KIF28P RIPOR1 GNAS MICAL1 RTTN NUP88 SORBS1 JMJD1C SETD2 MARK4 MYB PLCE1 | 7.78e-04 | 1020 | 186 | 16 | EFO_0004584 |
| Disease | monocyte percentage of leukocytes | ACAP1 PIEZO1 ARHGEF11 SHC3 EPS15L1 SEC16A TCF7L2 NPDC1 MED13L JMJD1C SETD2 MARK4 MYB | 7.91e-04 | 731 | 186 | 13 | EFO_0007989 |
| Disease | immature platelet fraction | 7.95e-04 | 114 | 186 | 5 | EFO_0009187 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 8.13e-04 | 7 | 186 | 2 | EFO_0020797 | |
| Disease | Ectrodactyly | 8.13e-04 | 7 | 186 | 2 | C0265554 | |
| Disease | Herpes encephalitis | 8.13e-04 | 7 | 186 | 2 | C0276226 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 8.13e-04 | 7 | 186 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | self rated health | 9.73e-04 | 31 | 186 | 3 | EFO_0004778 | |
| Disease | Squamous cell carcinoma of lung | 1.07e-03 | 32 | 186 | 3 | C0149782 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 1.08e-03 | 8 | 186 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.08e-03 | 8 | 186 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | reticulocyte measurement | SPHK2 SPIRE2 PIEZO1 NAB1 CTIF DENND2B ZEB2 BSN PAQR9 JMJD1C MICAL2 MARK4 RAI14 FHDC1 OSMR ELL | 1.08e-03 | 1053 | 186 | 16 | EFO_0010700 |
| Disease | Heart Failure, Diastolic | 1.17e-03 | 33 | 186 | 3 | C1135196 | |
| Disease | Tinnitus | 1.43e-03 | 130 | 186 | 5 | HP_0000360 | |
| Disease | multiple sclerosis | TRAF3 ARHGAP26 NAB1 SIDT1 NRROS USP31 EPS15L1 CBLB NCOR2 INAVA MYB | 1.45e-03 | 594 | 186 | 11 | MONDO_0005301 |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.48e-03 | 131 | 186 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.48e-03 | 131 | 186 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 1.48e-03 | 131 | 186 | 5 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.48e-03 | 131 | 186 | 5 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 1.69e-03 | 135 | 186 | 5 | C0087031 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.72e-03 | 10 | 186 | 2 | C1631597 | |
| Disease | Colorectal Carcinoma | ACAP1 RBM10 ZEB2 GNAS RASAL2 SHANK1 TCF7L2 ANK2 AKAP12 KCNH4 ARHGEF1 NEURL1 | 1.74e-03 | 702 | 186 | 12 | C0009402 |
| Disease | migraine disorder | 2.01e-03 | 357 | 186 | 8 | MONDO_0005277 | |
| Disease | waist-hip ratio | TRAF3 NAB1 KIAA2013 PRUNE1 MAST4 NAV3 TBX10 POC5 MINDY4 TCF7L2 ZNF407 JMJD1C RNF123 IGF1R CCDC171 ELL PLCE1 | 2.02e-03 | 1226 | 186 | 17 | EFO_0004343 |
| Disease | Intellectual Disability | 2.22e-03 | 447 | 186 | 9 | C3714756 | |
| Disease | lymphocyte count | ACAP1 SPHK2 TRAF3 IL16 PIEZO1 ARHGEF11 EPS15L1 NFATC2 RIPOR1 LIMA1 TCF7L2 NUP88 NPDC1 MED13L JMJD1C SETD2 MARK4 MYB PLCE1 | 2.35e-03 | 1464 | 186 | 19 | EFO_0004587 |
| Disease | colorectal cancer, endometrial neoplasm | 2.36e-03 | 42 | 186 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | brain disease (is_implicated_in) | 2.50e-03 | 12 | 186 | 2 | DOID:936 (is_implicated_in) | |
| Disease | obesity (is_implicated_in) | 2.67e-03 | 91 | 186 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | nevus count, cutaneous melanoma | 2.67e-03 | 91 | 186 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | reticulocyte count | SPHK2 SPIRE2 PIEZO1 NAB1 CTIF MAST2 DENND2B BSN TCF7L2 JMJD1C MICAL2 MARK4 RAI14 FHDC1 OSMR | 2.67e-03 | 1045 | 186 | 15 | EFO_0007986 |
| Disease | body surface area | TRAF3 ARHGAP26 SPATA31C1 POC5 GNAS PDE11A TICRR MED13L NCOR2 IGF1R SOWAHB | 2.68e-03 | 643 | 186 | 11 | EFO_0022196 |
| Disease | platelet aggregation | 2.88e-03 | 45 | 186 | 3 | GO_0070527 | |
| Disease | white matter hyperintensity measurement | 3.16e-03 | 302 | 186 | 7 | EFO_0005665 | |
| Disease | inositol measurement | 3.42e-03 | 14 | 186 | 2 | EFO_0010504 | |
| Disease | sitting height ratio | 4.11e-03 | 51 | 186 | 3 | EFO_0007118 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 4.11e-03 | 51 | 186 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | monocyte count | TRAF3 PIEZO1 MAST2 DENND2B SHC3 TLR8 TCF7L2 MED13L NCOR2 SETD2 WASF2 MARK4 ENAH TCF7L1 ELL MYB PLCE1 | 4.28e-03 | 1320 | 186 | 17 | EFO_0005091 |
| Disease | fourth ventricle volume measurement | 4.47e-03 | 16 | 186 | 2 | EFO_0010303 | |
| Disease | serum albumin measurement | 4.51e-03 | 592 | 186 | 10 | EFO_0004535 | |
| Disease | cardioembolic stroke | 4.55e-03 | 170 | 186 | 5 | EFO_1001976 | |
| Disease | Leukemia, Myelocytic, Acute | 4.90e-03 | 173 | 186 | 5 | C0023467 | |
| Disease | Malignant neoplasm of skin | 6.18e-03 | 59 | 186 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 6.18e-03 | 59 | 186 | 3 | C0037286 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 6.30e-03 | 19 | 186 | 2 | C0751884 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPSGSQAPSAAHPKR | 211 | P84996 | |
| DLTHRKSPSGPVKSP | 176 | Q9BVC5 | |
| PPKDSLRSTPSHGSV | 231 | Q9UBC2 | |
| LLKSHSRTLTPTPDG | 686 | Q92888 | |
| TPGAPTSPAEHRLLK | 31 | Q96GE9 | |
| DTLSSSTHLPPRLEP | 376 | P55199 | |
| GSPVSAAKHALPRPT | 591 | A0A096LP49 | |
| GSKSTIPRSADHPPK | 406 | Q9P2B7 | |
| PSAKGPTRLPTHDSD | 191 | A8MYA2 | |
| HSSLEAPRSPDTLAP | 291 | O43310 | |
| ELQSHAKSPPSPVER | 1321 | Q02952 | |
| DHSNLSIPSRAPLPA | 1256 | Q6TFL3 | |
| NPLSRHSPAPFSKSS | 4696 | Q6V0I7 | |
| ASRLPSSAVTPRAPH | 1276 | O00468 | |
| PPAKEPLASDSRNSH | 1481 | O15085 | |
| RSKPEPPSEDLGSLH | 556 | Q15027 | |
| PHSTPLLSSPDSEQR | 431 | Q58WW2 | |
| SSSRVLLKDRHPPAP | 61 | P78524 | |
| TSASLEKVRPHIAPP | 146 | Q8N7E2 | |
| SVETLPHLRPFPASS | 1126 | Q5T5Y3 | |
| LSPAALSPASTPHLA | 681 | P78312 | |
| LLPESPEPSASHALS | 1346 | Q96SN8 | |
| PPDSKSSPSVLIHSL | 406 | Q9P0K7 | |
| SVAAHRKSEPPPETL | 346 | Q9Y5P3 | |
| SVTHRPPLSPKSGAE | 6 | Q8IY67 | |
| KSELQSPTHPSSALP | 536 | P98175 | |
| TLCPDHPPSLGTRSK | 326 | Q7Z3H0 | |
| HPPSLGTRSKSVPEL | 331 | Q7Z3H0 | |
| DKPSSSELHSIPAPA | 476 | Q99650 | |
| AKSPLAAKSPPSLHL | 661 | O75665 | |
| PPSDPLRTHVKGLSN | 241 | Q9NWS1 | |
| EHLETKSLPSRSPPI | 361 | P26045 | |
| SPSGHTKLLPRSLAP | 301 | P32322 | |
| PVSPSAKTERHSPAS | 1856 | Q01484 | |
| NSSHKTPDSLEPSPL | 2446 | Q01484 | |
| LERSHSPPLKLTPAS | 316 | Q86TP1 | |
| SPEEPNKFHSLPRSS | 561 | Q9C0D6 | |
| APSKHFRSSKDPSAP | 276 | P23352 | |
| PPLISSAKHPSVLER | 1106 | Q9Y618 | |
| PPASASDPHREKTQS | 2011 | Q9Y618 | |
| PVSAAPSKAGLPRHI | 331 | Q13469 | |
| TDESSPVLSPRKPSH | 101 | Q8NA72 | |
| ATSHRKTSLPCPLPV | 41 | A1A4G5 | |
| APHSRLALQPSPLDK | 381 | Q96LI6 | |
| PPSVSPARHQLTSAL | 716 | Q9Y561 | |
| SSSLPPPASSKHKTA | 456 | Q71F56 | |
| REPSHPPKLLATSGK | 136 | O60299 | |
| HPPSKASSVEDTARP | 216 | Q9BY89 | |
| HLPKACDASPESTPL | 1061 | Q96JA1 | |
| VHPKPLSPDSRASSL | 356 | Q9UHB6 | |
| PDPTKARPASSFAHI | 36 | P09769 | |
| KPRSVDHPLPGSSLS | 536 | Q8NCE2 | |
| HSLSPADLGSPASPK | 171 | Q13506 | |
| KKHRPSTSSAAEPPL | 401 | Q2KJY2 | |
| RPSSAEPHRPLKITA | 926 | Q15652 | |
| PPSLTAKVLLHRTAP | 206 | Q9NQG7 | |
| QDPLKLHSSPASPSS | 1351 | Q9UPA5 | |
| PKHPSKSLAPAAISS | 3341 | Q9UPA5 | |
| SLIEHSKPPGSSSRP | 831 | Q13191 | |
| DPSASSSSLPLPDRH | 1306 | P08069 | |
| IPRPASDSKIISHPG | 821 | Q9Y6V0 | |
| TKPPNHRPAESSVST | 4931 | Q9Y6V0 | |
| KERGSSASHPPSPSL | 1096 | Q15154 | |
| HNPDPSERLLKPLSA | 211 | Q8IYT4 | |
| ALLRKASSLPPTTAH | 156 | Q9HCR9 | |
| GALKVSPSASAPRHP | 696 | Q9H5P4 | |
| TDSSLPASPKLPHNA | 1736 | Q8IVL0 | |
| TRLTAPPSLCSHLSP | 301 | Q14005 | |
| KTPVHSRSSSPIPLT | 391 | Q8N5Y2 | |
| AHSSPPKARFLRVPS | 2226 | Q9UM47 | |
| PKSLTRDTSHIPPLN | 276 | Q9H9L3 | |
| LDHRKPSPAQAAETP | 551 | Q8WX92 | |
| RAKAPPSLPHSASLR | 881 | Q9UJF2 | |
| LAPPLSPDHSSLEAK | 466 | P48681 | |
| EASPPTPSLLRHSFQ | 996 | Q9UQ05 | |
| TSQLLPGDKPRHPSL | 526 | A0A1B0GTW7 | |
| TSPALGHPESTPKSL | 446 | Q8N3F8 | |
| PKPPRSCSALARHAL | 831 | Q8TDZ2 | |
| SATSLLHTVSPEPPR | 471 | Q9UJY5 | |
| LTPPSSPELSRHLVK | 136 | O75840 | |
| ESSPRTPTPFKHALA | 461 | P10242 | |
| HKESALAPTAAPALP | 471 | Q86UU5 | |
| KSPAAPLSPASSLLA | 81 | P06850 | |
| ASTSRLPAPPARTLH | 666 | Q9P1Z3 | |
| SKASHDPLVPNSSPL | 166 | O95402 | |
| AGPLLKRSHSVPAPS | 346 | Q6ZV29 | |
| SAASRDPPASAKPLL | 31 | Q6ZVX9 | |
| SKLSLSPREHPLSPH | 1026 | Q86Y26 | |
| LARKESGHSTPPLPK | 106 | Q9NQX5 | |
| VGRSPDLSKSPAHNP | 751 | O43283 | |
| PAKALIPDSDHTPGS | 1761 | Q5VYJ5 | |
| APLQPSTSRAHKLPS | 386 | Q15884 | |
| PSPVPASSLQDHSRL | 86 | Q9NRJ2 | |
| PAPHDSALPARLLTS | 11 | Q9Y6Z2 | |
| SQHSTPAGLPPSRAK | 381 | Q8TES7 | |
| PLPFHDAKPSSRSSD | 761 | A4D2P6 | |
| TKHGSRSTSSLPPEP | 6 | Q14721 | |
| LPPKPLAARSSHLEN | 1931 | Q8N1I0 | |
| SPTGPLSSCHKLVDP | 1466 | Q9Y6R7 | |
| SRSFPHLSKPVAPGS | 16 | A1L170 | |
| TLPPNSRHGKLFSPS | 836 | Q96RY5 | |
| HSPLVTSPSANLKSP | 941 | Q86UU0 | |
| PEKASSADTSPHSPR | 171 | B7Z1M9 | |
| LSPNSPLPSEHRSLF | 246 | P41970 | |
| APLHPKRSPTSTGEA | 431 | Q96L34 | |
| KSAGSIPLSPLAHTP | 1336 | Q6P0Q8 | |
| GPPKTKHPDRSLSSQ | 2201 | O15021 | |
| PSVPLHTDRAPLDAK | 2271 | O15021 | |
| HTDRAPLDAKPQPTS | 2276 | O15021 | |
| AAHRPKRSSSLPLNP | 31 | Q6UWF9 | |
| PPKTRRGSSLHAEPS | 366 | Q5JRC9 | |
| PSPRLNASLSVHPEK | 61 | Q8TBB5 | |
| SLHRPKSTPLSQPSA | 531 | Q8N8S7 | |
| PHSVPDSSALPTKRK | 611 | Q9Y613 | |
| PSKRARPGPASTDSH | 116 | Q8NBF1 | |
| DISFLQPLSPPKTHR | 476 | Q3KP66 | |
| KSDSHGLLPTPRPSV | 256 | Q9BTV7 | |
| GSRHKPAPTKSAPAS | 276 | Q9BTV7 | |
| ALSPPHPALRISDKH | 416 | B7ZC32 | |
| QSLASVPSSLPPHAR | 46 | Q86YC3 | |
| GHSTPKLTPRSPARE | 721 | O75334 | |
| SPKRPKSISEPQHSD | 1116 | O94851 | |
| THRPALTPAAPLTTA | 1506 | Q6ZRI0 | |
| STVHPASPPLLCTRE | 496 | Q99567 | |
| RPLFGSLSPAEKTPH | 821 | Q8IVF1 | |
| RPPHDSSLSAPLPKL | 1591 | Q86VV8 | |
| SPSLKLPLSHSALPS | 1036 | Q9HCJ0 | |
| PSASPDLGKHSPLAL | 21 | Q6BEB4 | |
| PNPLPSRRAHSLTTA | 1141 | Q9P212 | |
| APPLRDSTLITPSHC | 226 | Q5VVP1 | |
| APPLRDSTLITPSHC | 226 | Q8IWB4 | |
| SKPPSCSERPLTLFH | 591 | Q9UNA1 | |
| TPAHSSGQPPRDAKL | 176 | Q9NZC9 | |
| LDTRLKPRPHAPDTA | 356 | Q92529 | |
| RSSPKEELHPAAPSQ | 1441 | O43166 | |
| PTTPGHAQSLSRPLK | 1101 | O60292 | |
| RDQTRSPKLSHSPQP | 116 | Q5T5P2 | |
| LGSKTPPASPHRVSD | 466 | Q5T5P2 | |
| KPSVAPRHPSTNSLL | 26 | Q9P032 | |
| PANPSSKRPLDAHLA | 656 | Q9P202 | |
| SPDPRTKHPQDLAST | 166 | P0DKV0 | |
| LPEKPHPATAAATLS | 11 | A6NNN8 | |
| PHSATAEEKPARALP | 216 | A6NEL2 | |
| LPASRALATPPKLHT | 271 | Q96JY6 | |
| SHRPLSSEPPAAKAS | 26 | Q5JTZ9 | |
| RRAPSPSLLPASEHK | 1996 | Q9Y566 | |
| ASEHKVSPAPRPSSL | 2006 | Q9Y566 | |
| SPPIPHLRALLSSSD | 741 | Q66K14 | |
| GKSELPPSLALHPST | 721 | P35523 | |
| RSPAHPTPLSRSASL | 651 | Q6P4Q7 | |
| APRPLLSVPARSHSS | 261 | O75333 | |
| TPSQKPAHLLSSSAP | 2196 | A4UGR9 | |
| APPLRDSTLITPSHC | 226 | Q5VYP0 | |
| SPSRLNPSDPNRKHV | 361 | Q32MQ0 | |
| NSLSHVPPKLPSSLR | 211 | Q9NR97 | |
| NPPLKLHTDRSAGTP | 16 | Q13114 | |
| SSSELSTPEKPPHQR | 1041 | Q92574 | |
| TQGATKPLSTPHRPS | 1196 | Q6ZU65 | |
| KPLSTPHRPSTASGS | 1201 | Q6ZU65 | |
| SSPGHDSPLDSKITP | 1161 | Q7Z2Z1 | |
| ARTPKLGPSIPNAHS | 91 | Q6P9A3 | |
| ERQKTTASSPPHLPS | 281 | Q4G0A6 | |
| APKQDSSPHLTSQRP | 3481 | Q96T58 | |
| SLSENDPLRFKPHPS | 121 | Q8NEJ9 | |
| TSKDPSRIHPDSLPK | 126 | O76050 | |
| PPRPQKTHSRASSLD | 481 | Q8NFH8 | |
| APPLRDSTLITPSHC | 226 | Q5TZJ5 | |
| EHSSPSVRLLPSAPQ | 1941 | O15027 | |
| ASPTPAHSLPRAKSE | 386 | Q9NRA0 | |
| APPLRDSTLITPSHC | 226 | Q5VU36 | |
| DTRSPSPAHLSNKVP | 166 | Q9HCS4 | |
| SHPPPEARPLSRKSS | 481 | Q8WVR3 | |
| SEHAPPAATSRKPLN | 46 | Q5XPI4 | |
| PASVSDPSHPLLSNR | 491 | Q8WWL2 | |
| PFLSLHRSPHGPSKL | 216 | Q8IUC6 | |
| PRAAASHPLSRKSIP | 31 | Q9P2N2 | |
| LLLAASPGHPAKSPR | 16 | Q9NXL6 | |
| DSPSFPRPSLLESHI | 1051 | Q92610 | |
| APSSLPHSRRALSPE | 966 | Q9BX66 | |
| LRVVPKTSSLPSPHD | 46 | Q7L0X0 | |
| PPPALLLAEATHKAS | 551 | Q9NQB0 | |
| PGNHDKSRTPRLPSS | 301 | P14679 | |
| KAPLLHSVSRDPSPF | 1371 | O43151 | |
| HSASESKPKERPAIP | 531 | Q86YV5 | |
| PIAPTCRSLESSPHS | 121 | A8MZF0 | |
| GHAKLSSSPPRASPV | 401 | Q9Y2K6 | |
| AHTPLNTPDPSTKLS | 1851 | Q9BYW2 | |
| SPLSREKLPSPSAAL | 2236 | Q8IUG5 | |
| LAGPKRSSVVSPSHP | 286 | Q9Y6W5 | |
| AIPPLRSHKPTVASL | 221 | F5GYI3 | |
| SSQASEPLCPLKHPS | 21 | Q8NA96 | |
| HLPATKASPSSPGRQ | 96 | O95049 | |
| SPKDSSHLLSPLRLH | 91 | Q6ZR37 | |
| TKISEAPFLHPAPRS | 2021 | Q5VWN6 | |
| RSHGPAAKPTLPVAT | 91 | Q9H609 | |
| PKRAEPREASPLHSL | 401 | Q92508 | |
| ASEPKRHPSTLPVIS | 481 | Q92558 | |
| LSAGPLRPTPAVKHS | 41 | Q5HYJ1 | |
| PFPPGKSRTSDHSLS | 1141 | Q70CQ4 | |
| ARPPDSGLHSLTVKP | 506 | Q9C0G0 | |
| SSPRTSPKHTSPLII | 821 | Q9Y4F4 | |
| ALSRGKSFPHSLPSP | 166 | O00744 | |
| PVEKLDHSRSNTPSP | 771 | O60315 | |
| LKSPKRPASPSSPEH | 226 | Q9H7L9 | |
| PSPAHSSRKPLTSPA | 731 | Q6ZS17 | |
| KPPRATASGKVSPDH | 286 | Q68DK2 | |
| SSIHSPSLRERSFPP | 1776 | Q68DK2 | |
| PPTTHTRLPASSIKK | 471 | Q6ZSZ6 | |
| SEAPKPASLPHTTRR | 131 | Q9BU19 | |
| PVLDPARSHSSTLSP | 601 | Q96T25 | |
| PSASPTGIPKHSLRK | 2076 | Q5THJ4 | |
| SCSPAPLLSPSLSHR | 371 | Q8IYS2 | |
| RLPSAPKPISHSVSS | 1671 | Q8IZF0 | |
| RVSLSPHSPLLSPKV | 1296 | O15069 | |
| QKDSSSAHLPPKDRP | 1586 | B2RTY4 |